Health Insurers May Sue if CMS Finalizes Obesity Drug Coverage Expansion

Insurance companies and others warned that CMS could be sued over its reinterpretation of existing law expanding coverage of GLP-1s for obesity treatment.

GLP-1s like Ozempic could be covered by Medicare for the treatment of obesity. (Shutterstock)

More from Medicare

More from Market Access